MFAP2 Promotes Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction] [0.03%]
MFAP2通过激活TGF-β / SMAD2/3信号通路促进胃癌细胞的上皮间质转化[撤稿]
[This retracts the article DOI: 10.2147/OTT.S160831.]. © 2026 Dove Medical Press.
Atractylodes Macrocephala Polysaccharides Regulate the Innate Immunity of Colorectal Cancer Cells by Modulating the TLR4 Signaling Pathway [Retraction] [0.03%]
苍术多糖通过调节TLR4信号通路调控结直肠癌细胞天然免疫属性的机制研究[撤稿]
[This retracts the article DOI: 10.2147/OTT.S219623.]. © 2026 Dove Medical Press.
Multi-Omics Analysis Identifies Phosphoglucomutase 2 as a Potential Target to Alleviate Chemoradiotherapy Resistance in Cervical Cancer Cells [0.03%]
多组学分析识别出葡萄糖-1,6-二磷酸酶2是潜在靶点可缓解宫颈癌细胞对放化疗的抵抗性
Huaxiang Yang,Qing Zheng,Xin Li et al.
Huaxiang Yang et al.
Background: As the core treatment for cervical cancer, chemoradiotherapy efficacy is often limited by tumor heterogeneity-driven resistance. During chemoradiotherapy, the tumor microenvironment undergoes dynamic remodelin...
Mechanisms and Emerging Strategies to Overcome Immunotherapy Resistance in Cold Tumours of Colorectal Cancer [0.03%]
结直肠癌“冷肿瘤”免疫治疗抵抗的机制和策略困境
Xinqiang Zhu,Beibei Ge,Linchun Wen
Xinqiang Zhu
Immunotherapy in colorectal cancer (CRC) presents a striking dichotomy. MSS/pMMR tumors account for approximately 95% of metastatic CRC cases, representing a substantial global health burden. While immune checkpoint inhibitors (ICIs) have r...
Bladder-Preserving Platforms for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer [0.03%]
卡介苗治疗无效的非肌层浸润性膀胱癌保膀胱治疗策略
Kaiyuan Zhang,Yanche Ren
Kaiyuan Zhang
Bacillus Calmette Guerin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC) remains a difficult clinical setting in which radical cystectomy offers the most reliable oncologic control but is not feasible or acceptable f...
A Nomogram Integrating HOXA9 Expression and Clinicopathological Factors for Predicting Postoperative Recurrence in Gastric Cancer: A Single-Center Retrospective Study [0.03%]
基于HOXA9表达和临床病理因素的胃癌术后复发预测列线图模型构建及验证：单中心回顾性研究
Jianze Weng,Jingwen Ying,Minming Xia et al.
Jianze Weng et al.
Objective: To develop a nomogram integrating HOXA9 expression with clinicopathological indicators for predicting postoperative recurrence risk in gastric cancer. ...
lncRNA FBXL19-AS1 Regulates Osteosarcoma Cell Proliferation, Migration and Invasion by Sponging miR-346 [Retraction] [0.03%]
长链非编码RNA FBXL19-AS1通过海绵吸附miR-346调节骨肉瘤细胞增殖、迁移和侵袭[撤稿]
[This retracts the article DOI: 10.2147/OTT.S160963.]. © 2026 Dove Medical Press.
Nodal Regulates Bladder Cancer Cell Migration and Invasion via the ALK/Smad Signaling Pathway [Retraction] [0.03%]
Nodal通过ALK/Smad信号通路调节膀胱癌细胞迁移和侵袭[撤稿]
[This retracts the article DOI: 10.2147/OTT.S177514.]. © 2026 Dove Medical Press.
Acquired BRAF-AGK Fusion Following Osimertinib Plus Savolitinib in EGFR-Mutated MET-Amplified Non-Small-Cell Lung Cancer: Durable Response to Gefitinib and Trametinib in a Case Report [0.03%]
奥希替尼联合萨瓦利替尼治疗表皮生长因子受体突变和间质上皮转化因子扩增的非小细胞肺癌患者出现获得性BRAF-AGK融合：gefitinib和trametinib联合用药的病例报告
An-Fu Lee,Shang-Yin Wu
An-Fu Lee
Background: Osimertinib is one of the standard first-line treatments for advanced epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC). Approximately 25% of patients acquire MET amplification...
Case Reports
OncoTargets and therapy. 2026 Jun 3:19:605699. DOI:10.2147/OTT.S605699 2026
Bergamottin Induces DNA Damage and Inhibits Malignant Progression in Melanoma by Modulating miR-145/Cyclin D1 Axis [Retraction] [0.03%]
柏格木醇诱导DNA损伤并通过调节miR-145/ Cyclin D1轴抑制黑色素瘤的恶性进展[撤稿]
[This retracts the article DOI: 10.2147/OTT.S275322.]. © 2026 Dove Medical Press.